AST Support of Docket No. FDA-2013-D-1358
Wednesday, February 19, 2014
The AST recently submitted a letter to the Food and Drug Administration regarding draft guidance for (510(k)) submissions for nucleic acid-based HLA test kits. The AST endorsed comments from the American Society for Histocompatibility and Immunogenetics (ASHI) regarding this FDA draft guidance for industry Docket.
News
- January 02, 2024For a limited time, the AST is offering an exclusive membership discount to transplant trainees.
- November 01, 2023I am thrilled to announce the successful conclusion of an extensive six-month search for our new staff leader. The Board is excited to introduce Ms.
- October 04, 2023The AST has partnered with the David Foster Foundation to spread awareness about the AST Living Donor Circle of Excellence and the ongoing need for organ and tissue donor registrations across North
- August 10, 2023In light of the U.S. Supreme Court’s decision in Students for Fair Admissions v.
- June 07, 2023The American Society of Transplantation (AST) announced the recipients of its 2023 Achievement Awards at
- June 06, 2023The American Society of Transplantation (AST) announced its newly elected 2023-2024 Board Members, including its new President, President-Elect, Secretary, and Councilors-at-Large.
- May 04, 2023Below is a Letter to the Editor in response to the recent New York Times Opinion Guest Essay "My Transplanted He
- April 06, 2023The AJT Instructions for Authors for multiple submission types have changed. The new version for Meeting Reports is listed below.
- April 05, 2023The AST recently submitted a letter to MolDX regarding the recent decision to limit reimbursement coverage for molecular diagnostics for transplantation such as donor derived cell free (cf)DNA and
- March 31, 2023The demand for life-saving organs continues to outpace the supply, with more than 100,000 individuals awaiting a transplant in the United States.
- January 11, 2023For a limited time, the AST is offering an exclusive membership discount to transplant trainees.
- January 01, 2023The AST announced Sylvie Leotin as the keynote speaker at the 2023 Cutting Edge of Transplantation. The meeting will be held February 23-25, 2023, in Scottsdale, AZ.
- November 15, 2022On November 15, 2022, AST, ASTS, and ISHLT posted a joint statement on COVID-19 vaccination in transplant recipients and candidates.
- November 03, 2022The AST is seeking experienced and knowledgeable people to fill available positions on several of its committees.
- September 28, 2022
- August 31, 2022The new Recommendations for Use of Maintenance Immunosuppression in Solid Organ Transplantation have been endorsed by the American College of Clinical Pharmacy, the American Society of Transplantat
- August 10, 2022It’s been 4 years since the transplant community was able to be together in person at the Transplant Games of America and AST was excited to finally be together again with recipients, donor familie